Cargando…

Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is a common type of cancer, with a mortality of >80% worldwide. Gigantol is a bibenzyl compound that displays anticancer activity. The aim of the present study was to determine the biological activity of gigantol in NSCLC and to elucidate the underlying molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yuxing, Hao, Yi, Xu, Hui, Chen, Kai, Ren, Baozhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495587/
https://www.ncbi.nlm.nih.gov/pubmed/34630671
http://dx.doi.org/10.3892/etm.2021.10752
_version_ 1784579585987313664
author Cai, Yuxing
Hao, Yi
Xu, Hui
Chen, Kai
Ren, Baozhong
author_facet Cai, Yuxing
Hao, Yi
Xu, Hui
Chen, Kai
Ren, Baozhong
author_sort Cai, Yuxing
collection PubMed
description Non-small cell lung cancer (NSCLC) is a common type of cancer, with a mortality of >80% worldwide. Gigantol is a bibenzyl compound that displays anticancer activity. The aim of the present study was to determine the biological activity of gigantol in NSCLC and to elucidate the underlying molecular mechanism of its action. The expression of DEK proto-oncogene (DEK) was measured in NSCLC tissues and cell lines by reverse transcription-quantitative PCR (RT-qPCR). The results suggested that DEK levels were significantly increased in NSCLC tissues and cell lines compared with adjacent non-tumor tissues and BEAS-2B normal bronchial epithelial cells, respectively. A549 cells were exposed to a series of gigantol concentrations (0, 25, 50 and 100 µM) and transfected with DEK small interfering RNA. The results of cell viability measured by MTT assay indicated that gigantol significantly decreased cell viability. Additionally, cell proliferation was assessed by CCK-8 and apoptosis was measured by flow cytometry. In comparison with the control group, gigantol treatment inhibited cell proliferation and promoted apoptosis, whereas DEK knockdown increased gigantol-induced suppression of proliferation and acceleration of apoptosis. Additionally, DEK overexpression reversed gigantol-induced effects on proliferation and apoptosis. Moreover, compared with the control group, gigantol treatment decreased Ki-67 and Bcl-2 expression levels, increased Bax expression levels and inactivated the Wnt/β-catenin signaling pathway, as assessed by RT-qPCR and/or western blot. DEK knockdown further increased gigantol-induced effects, but DEK overexpression reversed gigantol-induced effects. To conclude, the results of the present study suggested that gigantol inhibited cell proliferation and induced apoptosis by decreasing Ki-67 and Bcl-2 expression, increasing Bax expression and activating the Wnt/β-catenin signaling pathway by regulating DEK. The present study indicated the therapeutic potential of gigantol in patients with NSCLC. In addition, DEK may serve as a novel therapeutic target to enhance the effects of gigantol treatment.
format Online
Article
Text
id pubmed-8495587
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-84955872021-10-07 Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer Cai, Yuxing Hao, Yi Xu, Hui Chen, Kai Ren, Baozhong Exp Ther Med Articles Non-small cell lung cancer (NSCLC) is a common type of cancer, with a mortality of >80% worldwide. Gigantol is a bibenzyl compound that displays anticancer activity. The aim of the present study was to determine the biological activity of gigantol in NSCLC and to elucidate the underlying molecular mechanism of its action. The expression of DEK proto-oncogene (DEK) was measured in NSCLC tissues and cell lines by reverse transcription-quantitative PCR (RT-qPCR). The results suggested that DEK levels were significantly increased in NSCLC tissues and cell lines compared with adjacent non-tumor tissues and BEAS-2B normal bronchial epithelial cells, respectively. A549 cells were exposed to a series of gigantol concentrations (0, 25, 50 and 100 µM) and transfected with DEK small interfering RNA. The results of cell viability measured by MTT assay indicated that gigantol significantly decreased cell viability. Additionally, cell proliferation was assessed by CCK-8 and apoptosis was measured by flow cytometry. In comparison with the control group, gigantol treatment inhibited cell proliferation and promoted apoptosis, whereas DEK knockdown increased gigantol-induced suppression of proliferation and acceleration of apoptosis. Additionally, DEK overexpression reversed gigantol-induced effects on proliferation and apoptosis. Moreover, compared with the control group, gigantol treatment decreased Ki-67 and Bcl-2 expression levels, increased Bax expression levels and inactivated the Wnt/β-catenin signaling pathway, as assessed by RT-qPCR and/or western blot. DEK knockdown further increased gigantol-induced effects, but DEK overexpression reversed gigantol-induced effects. To conclude, the results of the present study suggested that gigantol inhibited cell proliferation and induced apoptosis by decreasing Ki-67 and Bcl-2 expression, increasing Bax expression and activating the Wnt/β-catenin signaling pathway by regulating DEK. The present study indicated the therapeutic potential of gigantol in patients with NSCLC. In addition, DEK may serve as a novel therapeutic target to enhance the effects of gigantol treatment. D.A. Spandidos 2021-11 2021-09-17 /pmc/articles/PMC8495587/ /pubmed/34630671 http://dx.doi.org/10.3892/etm.2021.10752 Text en Copyright: © Cai et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Cai, Yuxing
Hao, Yi
Xu, Hui
Chen, Kai
Ren, Baozhong
Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer
title Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer
title_full Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer
title_fullStr Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer
title_full_unstemmed Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer
title_short Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer
title_sort gigantol inhibits cell proliferation and induces apoptosis by regulating dek in non-small cell lung cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495587/
https://www.ncbi.nlm.nih.gov/pubmed/34630671
http://dx.doi.org/10.3892/etm.2021.10752
work_keys_str_mv AT caiyuxing gigantolinhibitscellproliferationandinducesapoptosisbyregulatingdekinnonsmallcelllungcancer
AT haoyi gigantolinhibitscellproliferationandinducesapoptosisbyregulatingdekinnonsmallcelllungcancer
AT xuhui gigantolinhibitscellproliferationandinducesapoptosisbyregulatingdekinnonsmallcelllungcancer
AT chenkai gigantolinhibitscellproliferationandinducesapoptosisbyregulatingdekinnonsmallcelllungcancer
AT renbaozhong gigantolinhibitscellproliferationandinducesapoptosisbyregulatingdekinnonsmallcelllungcancer